Watchlist

Watchlist
Adaptimmune Therapeutics plc (ADAP)
Adaptimmune Therapeutics plc (ADAP)
Nasdaq Biotech Index: 54 to be added, 15 removed
Changes will become effective prior to the open next Monday. ETF: IBB More news on: iShares Nasdaq Biotechnology ETF, Arbutus Biopharma Corp, Aclaris Therapeutics, Healthcare stocks news, News on ETFs, Read more …
Adaptimmune: Is Now The Time To Adopt This Stock For Your Stock Portfolio?
Investing Thesis I follow several biotechnology companies based on my thinking they are on the cutting edge of new therapies. One aspect of investing in biotechs is the issue of timing your investment to maximize your potential return. The wait is often more than what you would hope, therefo…
Biotech Forum Daily Digest: Behind Omeros' Blowout Results
A cynic is a man who, when he smells flowers, looks around for a coffin . H.L. Mencken The high beta parts of the market continued to take it on the shin while the large cap indices remain placid last week. The S&P 500 and Dow posted small losses on the week as both …
Adaptimmune's NY-ESO SPEAR T-cell therapy shows encouraging effect in synovial sarcoma pilot study
Updated results from a pilot study assessing Adaptimmune Therapeutics' ( ADAP -0.6% ) NY-ESO SPEAR T-cells in patients with synovial sarcoma showed a positive effect. The data were presented at the annual CTOS meeting in Hawaii. More news on: Adaptimmune Therapeutics plc, GlaxoSmithKl…
Adaptimmune Therapeutics' (ADAP) CEO James Noble on Q3 2017 Results - Earnings Call Transcript
Adaptimmune Therapeutics Plc (ADAP) Q3 2017 Earnings Conference Call November 2, 2017 08:00 AM ET Executives Juli Miller - Media Relations James Noble - Chief Executive Officer Adrian Rawcliffe - Chief Financial Officer Helen Tayton Martin - Chief Business Officer Bill Bertr…
Adaptimmune EPS of $0.00
Adaptimmune (NASDAQ: ADAP ): Q3 EPS of $0.00 may not be comparable to consensus of -$0.23. More news on: Adaptimmune Therapeutics plc, Earnings news and commentary, Healthcare stocks news, Read more …
Adaptimmune Therapeutics (ADAP) Presents At LEERINK Partners Roundtable Series On Rare Disease And Immuno-Oncology - Slideshow
The following slide deck was published by Adaptimmune Therapeutics plc in conjunction with this Read more …
Faison's Weekend Review And Scans
Over the past few months, readers have been asking me where and how to scan and find ideas. From busted IPOs to insider buys, technical breakouts to unusual volume, there are plenty of ways to find interesting ideas that would take much longer than this piece can cover. Instead, I chose just a…
Midday Gainers / Losers
Gainers: KURA +86% . NLNK +34% . EBIO +23% . ZUMZ +21% . ERN +18% . VTL +17% . SHOS +15% . FCSC +14% . ADAP +14% . VERI +13% . More news on: Kura Oncology, NewLink Genetics Corporation, Eleven Biotherapeutics, Inc., Stocks on the move, Read more …
Premarket Gainers as of 9:05 am
RH +40% on lifting FY guidance. More news on: RH, Cleantech Solutions International, Inc., Cabela's Incorporated, Stocks on the move, Read more …
Adaptimmune beats by $0.01, misses on revenue
Adaptimmune (NASDAQ: ADAP ): Q2 EPS of -$0.24 beats by $0.01 . More news on: Adaptimmune Therapeutics plc, Earnings news and commentary, Healthcare stocks news, Read more …
Adaptimmune Therapeutics plc (ADAP)